INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 1 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,000 | -25.0% | 14,000 | 0.0% | 0.00% | – |
| Q2 2020 | $4,000 | +300.0% | 14,000 | +55.6% | 0.00% | – |
| Q1 2020 | $1,000 | -75.0% | 9,000 | 0.0% | 0.00% | – |
| Q4 2019 | $4,000 | -33.3% | 9,000 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -68.4% | 9,000 | +95.7% | 0.00% | -100.0% |
| Q2 2019 | $19,000 | – | 4,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 809,804 | $4,140,000 | 0.60% |
| SABBY MANAGEMENT, LLC | 514,878 | $2,652,000 | 0.14% |
| Migdal Insurance & Financial Holdings Ltd. | 497,200 | $2,542,000 | 0.06% |
| Renaissance Technologies | 12,944 | $66,000 | 0.00% |
| DEUTSCHE BANK AG\ | 12,724 | $65,000 | 0.00% |